Inventor · disambiguated record
Robin Thurmond
Also filed as: THURMOND ROBIN · THURMOND ROBIN L
11 granted patents·15 pending applications·91 citations·filing 2000–2017
89Inventor score
Files withORTHO MCNEIL PHARM INC8JANSSEN PHARMACEUTICA NV5BREITENBUCHER J G1BUTLER CHRISTOPHER R1CAI HUI1
Top patents by PatentIndex Score
26 records- 0189US6803362B2Heterocyclic compoundsORTHO MCNEIL PHARM INC·Filed 2002·Granted Oct 12, 2004·38 cites·37 claims
- 0283US6458552B1Metalloprotease peptide substrates and methodsORTHO MCNEIL PHARM INC·Filed 2000·Granted Oct 1, 2002·9 cites·4 claims
- 0382US6583155B2Method for treating allergies using substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2002·Granted Jun 24, 2003·15 cites·12 claims
- 0481US8841287B2Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptorCAI HUI·Filed 2009·Granted Sep 23, 2014·6 cites·31 claims
- 0576US7332494B2Method for treating allergies using substituted pyrazolesJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Feb 19, 2008·7 cites·2 claims
- 0674US6369032B1Method for treating allergiesORTHO MCNEIL PHARM INC·Filed 2001·Granted Apr 9, 2002·7 cites·18 claims
- 0773US6780985B2Polynucleotide and polypeptide sequences of Canine Cathepsin SORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 24, 2004·3 cites·8 claims
- 0871US6579896B2Method for treating allergies using substituted pyrazolesORTHO MCNEIL PHARM INC·Filed 2001·Granted Jun 17, 2003·5 cites·9 claims
- 0959US9732087B2Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 15, 2017·0 cites·21 claims
- 1057US2011076324A1Use of Histamine H4 antagonist for the treatment of post-operative adhesionsJANSSEN PHARMACEUTICA NV·Filed 2009·Application pending·0 cites
- 1156US2004259206A1Polynucleotide and polypeptide sequences of monkey cathepsin SFiled 2004·Application pending·0 cites
- 1256US2004259207A1Polynucleotide and polypeptide sequences of canine cathepsin SFiled 2004·Application pending·0 cites
- 1355US7026132B2Method of monitoring the effect of Cathepsin S inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Apr 11, 2006·1 cites·3 claims
- 1455US2007105841A1Method for treating allergies using substituted pyrazolesBREITENBUCHER J G·Filed 2006·Application pending·0 cites
- 1554US6784288B2Polynucleotide and polypeptide sequences of monkey cathepsin SORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 31, 2004·0 cites·8 claims
- 1653US2007117785A1Substituted pyrazoles and methods of treatment with substituted pyrazolesBUTLER CHRISTOPHER R·Filed 2006·Application pending·0 cites
- 1752US2005085487A1Heterocyclic compoundsFiled 2004·Application pending·0 cites
- 1852US2009069343A1Combination Histamine H1R and H4R Antagonist Therapy for Treating PruritusDUNFORD PAUL J·Filed 2007·Application pending·0 cites
- 1951US2017298022A1Diamino-Pyridine, Pyrimidine, and Pyridazine Modulators of the Histamine H4 ReceptorJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2049US2013202685A1Use of a histamine H4 antagonist for the treatment of post-operative adhesionsJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 2147US2005101587A9Method for treating allergies using substituted pyrazolesFiled 2001·Application pending·0 cites
- 2244US2008102476A1Analyzing Histamine H4 Receptor-Mediated Effects In Whole BloodKARLSSON LARS·Filed 2004·Application pending·0 cites
- 2342US2004132715A1Method to treat allergic rhinitisFiled 2003·Application pending·0 cites
- 2442US2004105856A1Use of histamine H4 receptor antagonist for the treatment of inflammatory responsesFiled 2002·Application pending·0 cites
- 2540US2004127395A1Use of histamine H4 receptor modulators for the treatment of allergy and asthmaFiled 2003·Application pending·0 cites
- 2638US2003133931A1Use of histamine H4 receptor antagonist for the treatment of inflammatory responsesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robin Thurmond files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →